Ovarian Cancer | Consensus or Controversy? Current and Future Management of Ovarian Cancer

from Research To Practice | Oncology Videos · host Dr. Neil Love

Featuring perspectives from Drs Ursula Matulonis and Debra Richardson, including the following topics: PROLOGUE: Antibody-Drug Conjugates Across Oncology (0:00) Antibody-Drug Conjugates in Ovarian Cancer: Mirvetuximab Soravtansine (10:03) Antibody-Drug Conjugates in Ovarian Cancer: Upifitamab Rilsodotin (29:09) Tumor Treating Fields (41:35) PARP Inhibitor Update (47:29) CME information and select publications

Episode metadata supplied by the publisher feed · Published Nov 30, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Ovarian Cancer | Consensus or Controversy? Current and Future Management of Ovarian Cancer

0:00 1:03:04

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Research To Practice | Oncology Videos?

This episode is 1 hour and 3 minutes long.

When was this Research To Practice | Oncology Videos episode published?

This episode was published on November 30, 2022.

Can I download this Research To Practice | Oncology Videos episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!